Shunya Oka

Title: Shunya Oka - Innovator in ADP-Ribosylation Research

Introduction

Shunya Oka is a prominent inventor based in Niigata, Japan. He has made significant contributions to the field of biochemistry, particularly in the area of ADP-ribosylation. His work focuses on the mechanisms and applications of ADP-ribosyl acceptor hydrolase 3 (ARH3) polypeptides.

Latest Patents

Shunya Oka holds a patent for "ADP-ribosyl acceptor hydrolase 3 (ARH3) polypeptides and methods of use." This patent provides methods for catalyzing the release of ADP-ribose from poly(ADP-ribose) or O-acetyl-ADP-ribose. Additionally, it outlines methods for modifying DNA repair or chromatin structure by introducing agents that modify the activity of an ARH3 polypeptide, or its variants or fragments. The patent also includes methods for screening molecules involved in the poly(ADP-ribosyl)ation of proteins or O-acetyl-ADP-ribose content, as well as methods for treating disorders by altering the activity of an ARH3 protein.

Career Highlights

Shunya Oka is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His innovative research has positioned him as a key figure in the study of ADP-ribosylation and its implications in various biological processes.

Collaborations

Shunya Oka has collaborated with notable colleagues, including Jiro Kato and Atsushi Kasamatsu. These collaborations have further enhanced the impact of his research in the scientific community.

Conclusion

Shunya Oka's contributions to the field of biochemistry, particularly through his patent on ARH3 polypeptides, highlight his role as an influential inventor. His work continues to pave the way for advancements in understanding and treating disorders related to ADP-ribosylation.